Q2 EPS Estimate for Colgate-Palmolive Decreased by Analyst

Colgate-Palmolive (NYSE:CL - Free Report) - Research analysts at Zacks Research reduced their Q2 2025 earnings per share (EPS) estimates for Colgate-Palmolive in a report released on Thursday, May 8th. Zacks Research analyst R. Lohia now forecasts that the company will earn $0.89 per share for the quarter, down from their previous estimate of $0.94. The consensus estimate for Colgate-Palmolive's current full-year earnings is $3.75 per share. Zacks Research also issued estimates for Colgate-Palmolive's Q3 2025 earnings at $0.91 EPS, Q4 2025 earnings at $0.94 EPS, FY2025 earnings at $3.65 EPS, Q2 2026 earnings at $0.95 EPS, Q3 2026 earnings at $0.97 EPS, Q4 2026 earnings at $1.01 EPS, FY2026 earnings at $3.90 EPS, Q1 2027 earnings at $1.03 EPS and FY2027 earnings at $4.15 EPS.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The company had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. During the same quarter in the prior year, the business posted $0.86 EPS. The business's revenue was down 3.0% compared to the same quarter last year.

Several other brokerages have also recently commented on CL. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. Wells Fargo & Company upped their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 2nd. Piper Sandler decreased their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research note on Monday, March 31st. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Finally, UBS Group boosted their target price on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research note on Thursday, April 17th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $102.39.

Colgate-Palmolive Stock Performance

Shares of CL traded down $1.26 during midday trading on Monday, reaching $87.88. 5,458,127 shares of the stock were exchanged, compared to its average volume of 4,645,779. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The company has a market cap of $71.22 billion, a P/E ratio of 24.97, a PEG ratio of 4.20 and a beta of 0.39. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The stock's 50 day simple moving average is $92.16 and its 200 day simple moving average is $91.43.

Colgate-Palmolive announced that its Board of Directors has authorized a share buyback plan on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback plans are often an indication that the company's leadership believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be given a dividend of $0.52 per share. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date of this dividend is Thursday, April 17th. Colgate-Palmolive's payout ratio is presently 58.76%.

Institutional Trading of Colgate-Palmolive

A number of hedge funds and other institutional investors have recently modified their holdings of CL. Norges Bank purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $912,375,000. Diamond Hill Capital Management Inc. bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $348,718,000. AMF Tjanstepension AB boosted its holdings in shares of Colgate-Palmolive by 1,088.8% in the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company's stock worth $233,584,000 after purchasing an additional 2,353,268 shares during the period. Nuveen LLC bought a new position in shares of Colgate-Palmolive during the 1st quarter valued at approximately $217,593,000. Finally, Barclays PLC raised its holdings in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after buying an additional 2,132,747 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.